The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8) , 1334-1340
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- P2Y 12 H2 Haplotype Is Associated With Peripheral Arterial DiseaseCirculation, 2003
- Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analysesBlood, 2002
- The G20210A mutation does not affect the stability of prothrombin mRNA in vivoBlood, 2002
- Prevalence and Therapeutic Control of Hypertension in 30 000 Subjects in the WorkplaceHypertension, 2001
- Polymorphisms in the 5′ Regulatory Region of the Tissue Factor Gene and the Risk of Myocardial Infarction and Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severityBlood Coagulation & Fibrinolysis, 1998
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart diseaseThe Lancet, 1993